The Effect of Virtual Reality Application Used During Endoscopy on Pain, Anxiety and Vital Signs: A Mixed Methods Study
Launched by İBRAHİM NAS · Oct 18, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Objective: In this study, the effect of virtual reality application used during upper gastrointestinal endoscopy on pain, anxiety and vital signs will be investigated. The research will be conducted as a mixed methods research including quantitative and qualitative methods. The exploratory sequence mixed design model, one of the mixed method designs, will be used in the research.
The research was carried out in the endoscopy unit of a university hospital in Van between November 2022 and March 2023. This research, in which an exploratory sequential mixed design was used, consists of two sta...
Gender
ALL
Eligibility criteria
- Criteria:
- Inclusion criteria:
- • Inclusion criteria for the quantitative study;
- • 18 years and older,
- • who can read and write Turkish,
- • without mental problems,
- • Having no vision, hearing or perception problems,
- • Diagnostic endoscopy was performed,
- • No sedation before and during the procedure
- • who volunteered to participate in the study,
- • Those who have not taken analgesics in the last 8 hours
- • Qualitative research inclusion criteria;
- • in the experimental group,
- • who volunteered to participate in the research
- Exclusion Criteria:
- • Exclusion criteria from quantitative section research;
- • sedation applied,
- • who want to withdraw from the study,
- • Patients using analgesics or anti-anxiety medications before and during the procedure
- • Exclusion criteria from qualitative departmental research;
- • • Those in the control group
About İbrahi̇m Nas
İbrahim Nas is a distinguished clinical trial sponsor recognized for its commitment to advancing medical research and innovation. With a focus on developing cutting-edge therapies and treatments, the organization collaborates with leading researchers and institutions to design and implement robust clinical studies. İbrahim Nas prioritizes patient safety and ethical standards, ensuring that all trials adhere to rigorous regulatory guidelines. Through its dedication to scientific excellence and a patient-centered approach, İbrahim Nas aims to contribute significantly to the enhancement of healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Van, , Turkey
Patients applied
Trial Officials
GÜLAY İPEK ÇOBAN, Prof.Dr.
Principal Investigator
Ataturk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials